The Neurobiology Research Group of the Molecular Basis of Disease Research Program is a rapidly emerging research focus of the Griffith Health Institute. We are engaged in a variety of clinical and basic science research areas in the neurosciences including:
- Genetics and multiple sclerosis
- Genes in autoimmune disorders
- Molecular mechanisms of neurodegeneration
- Diagnostics of Parkinson's disease
- Role of metals in biological systems
- Effects of alcohol abuse on the brain
- Molecular mechanisms of brain damage
- Identification of craving biomarkers
- Neurobiology of nicotinic receptors
- Nicotinic receptors in Alzheimer’s disease
- Neurotoxins from animal venoms
The broad aim of the Neurobiology Research Group is to identify the genes and decipher the molecular mechanisms that underpin common neurological, neurodegenerative and psychiatric disorders including multiple sclerosis, Parkinson’s and Alzheimer’s diseases and alcohol addiction as well as understand the pharmacological mechanisms responsible for the lethal effects of neurotoxins present in animal venoms.